ADIM
AMGN icon

Alpha DNA Investment Management’s Amgen AMGN Stock Holding History

Alpha DNA Investment Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-234
Closed -$58K – 127
2021
Q1 		$58K Buy
234
+26
+13% +$6.2K 0.07% 152
2020
Q4 		$47K Buy
+208
New +$48K 0.05% 186

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Alpha DNA Investment Management's AMGN Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Amgen (AMGN) in Q2 2021, closing a stake of 234 shares — an estimated $58K sold.

Alpha DNA Investment Management first reported a position in AMGN in Q4 2020 and held it in 2 quarters. The position peaked at $58K in Q1 2021. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 234 Amgen shares in Q2 2021, an estimated $58K.
  • Alpha DNA Investment Management first reported a position in Amgen in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Amgen position peaked at $58K in Q1 2021.
  • 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.